Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy

AIDS. 2021 Apr 1;35(5):843-845. doi: 10.1097/QAD.0000000000002809.

Authors

Douglas Drak^{1

2}, Rumbi Dahwa³, Edward Reakes⁴, Jack E Heron⁴, Tinei Shamu^{5

6}, Cleophas Chimbetete⁵, David M Gracey^{1

4}

Affiliations

¹ Central Clinical School, University of Sydney, Camperdown.
² Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia.
³ Department of Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
⁴ Renal Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
⁵ Newlands Clinic, Newlands, Harare, Zimbabwe.
⁶ Institute of Social and Preventive Medicine, University of Bern, Switzerland.

PMID: 33724258
DOI: 10.1097/QAD.0000000000002809

No abstract available

MeSH terms

Adolescent
Anti-HIV Agents* / therapeutic use
Anti-Retroviral Agents / therapeutic use
Antiretroviral Therapy, Highly Active
HIV Infections* / drug therapy
Humans

Substances

Anti-HIV Agents
Anti-Retroviral Agents